We analyzed the cost-effectiveness of hepatitis A vaccination regimens
using a mathematical simulation model. Passive immunization and two a
ctive vaccination strategies [with and without prior screening] were c
ompared with ''doing nothing.'' Hepatitis A antibodies were determined
in 2,325 Dutch marines; other input data were retrieved from publishe
d and unpublished sources. The prevalence of hepatitis A antibody was
14%. Screening before vaccination was identified as appropriate at a p
revalence > 20%, Passive immunization was the cheapest prevention for
a single 6-month deployment per 10 years. The inactivated vaccine cont
aining 1,440 enzyme-linked immunosorbent assay units without prior scr
eening was identified as the best option for more frequent deployments
. It was cost-saving with two or more missions per 10 years. A 5.3% he
patitis A attack rate validated the investment for this policy. Overal
l, immunization with inactivated hepatitis A vaccine without prior scr
eening proved to be the optimum strategy for troops at regular risk.